Company Overview of Hangzhou Ausia Biological Technology Company, Ltd
Hangzhou Ausia Biological Technology Company, Ltd., a contract manufacturing organization, specializes in aseptic manufacturing of lyophilized vials. The company’s products include lyophilized powder for injections and liquid fills; and azithromycin, ribonucleic acid III, thymopentin, pantoprazole sodium, cytidine disodium triphosphate, carbazochrome sodium sulfonate, and adenosine cyclophosphate for injections. It offers manufacturing services to pharmaceutical and health care firms. The company was founded in 1993 and is based in Hangzhou, China.
No. 1 First Road
Founded in 1993
86 571 8691 3582
86 571 8691 3589
Key Executives for Hangzhou Ausia Biological Technology Company, Ltd
Similar Private Companies By Industry
|Aleph Biological Co., Ltd.||Asia|
|Allist Pharmaceuticals, Inc.||Asia|
|Alpha Pharmaceutical Co.,Ltd. Jiangsu Province||Asia|
|Amerigen Pharmaceuticals Limited||Asia|
Recent Private Companies Transactions
December 25, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Hangzhou Ausia Biological Technology Company, Ltd, please visit www.ausia.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.